LENZ
LENZ Therapeutics
LENZ
LENZ
66 hedge funds and large institutions have $81.2M invested in LENZ Therapeutics in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.38% more ownership
Funds ownership: 7.31% → 7.68% (+0.38%)
0% more call options, than puts
Call options by funds: $1.53M | Put options by funds: $1.53M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
66
Holding in Top 10
2
Calls
$1.53M
Puts
$1.53M
Top Buyers
| 1 | +$3.13M | |
| 2 | +$2.14M | |
| 3 | +$915K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$704K |
| 5 |
CA
CHI Advisors
New York
|
+$600K |
Top Sellers
| 1 | -$2.38M | |
| 2 | -$1.28M | |
| 3 | -$1.01M | |
| 4 |
WSL
Western Standard LLC
Los Angeles,
California
|
-$833K |
| 5 |
Morgan Stanley
New York
|
-$344K |